Cargando…

The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease

The diagnosis of dementia is challenging and early stages are rarely detected limiting the possibilities for early intervention. Another challenge is the overlap in the clinical features across the different dementia types leading to difficulties in the differential diagnosis. Identifying biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inekci, Dilek, Jonesco, Ditte Svendsen, Kennard, Sophie, Karsdal, Morten Asser, Henriksen, Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426721/ https://www.ncbi.nlm.nih.gov/pubmed/26029153 http://dx.doi.org/10.3389/fneur.2015.00090

Ejemplares similares

The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer’s disease, other types of dementia and non-demented controls: A cross-sectional study
por: Jonesco, Ditte S., et al.
Publicado: (2020)

A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest
por: Jonesco, Ditte S., et al.
Publicado: (2019)

Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study
por: Neergaard, Jesper Skov, et al.
Publicado: (2018)

Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls
por: Nedergaard, Anders, et al.
Publicado: (2015)

Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study
por: Neergaard, Jesper Skov, et al.
Publicado: (2016)

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013)

The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy
por: Sonne, Nina, et al.
Publicado: (2022)

Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
por: Thorlacius‐Ussing, Jeppe, et al.
Publicado: (2023)

Matrix metalloproteinase-degraded type I collagen is associated with APOE/TOMM40 variants and preclinical dementia
por: Tang, Man-Hung Eric, et al.
Publicado: (2020)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile
por: Larsen, Anna Thorsø, et al.
Publicado: (2021)

A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation
por: Luo, Yunyun, et al.
Publicado: (2018)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
por: Sparding, Nadja, et al.
Publicado: (2023)

Neo-Epitopes—Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis
por: Maijer, Karen I., et al.
Publicado: (2016)

The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
por: Genovese, Federica, et al.
Publicado: (2014)

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
por: Hurkmans, Daan P, et al.
Publicado: (2020)

The Inhibitory Effect of Salmon Calcitonin on Tri-Iodothyronine Induction of Early Hypertrophy in Articular Cartilage
por: Chen-An, Pingping, et al.
Publicado: (2012)

Serological muscle loss biomarkers: an overview of current concepts and future possibilities
por: Nedergaard, Anders, et al.
Publicado: (2012)

Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model
por: Katri, Anna, et al.
Publicado: (2021)

Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
por: Willumsen, Nicholas, et al.
Publicado: (2019)

The activation fragment of PAR2 is elevated in serum from patients with rheumatoid arthritis and reduced in response to anti-IL6R treatment
por: Kalogera, Stefania, et al.
Publicado: (2021)

Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
por: Jensen, Christina, et al.
Publicado: (2018)

Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer’s Disease
por: Sun, Zhi-Ting, et al.
Publicado: (2021)

A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders
por: Holm Nielsen, Signe, et al.
Publicado: (2020)

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
por: Baird, Alison L., et al.
Publicado: (2015)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017)

Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women
por: Bertelsen, Ditte Marie, et al.
Publicado: (2018)

Microglial immunophenotype in dementia with Alzheimer’s pathology
por: Minett, Thais, et al.
Publicado: (2016)

Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023)

Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
por: Pehrsson, Martin, et al.
Publicado: (2023)

Correction: Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis
por: Pehrsson, Martin, et al.
Publicado: (2023)

Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
por: Di Tella, Sonia, et al.
Publicado: (2021)

Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
por: Andreassen, Kim Vietz, et al.
Publicado: (2014)

Behavioral and psychological symptoms in dementia is not a unitary concept: A critical review with emphasis on Alzheimer’s disease
por: Laks, Jerson, et al.
Publicado: (2008)

Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage Turnover
por: Madsen, Suzi Hoegh, et al.
Publicado: (2011)

The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)
por: Bay-Jensen, Anne-C., et al.
Publicado: (2016)

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4d2hiqujc24bs5tidv71fp3sjf